Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control

L. Demey (Brussels, Belgium), A. Van Muylem (Brussels, Belgium), S. Perez-Bogerd (Brussels, Belgium), A. Haccuria (Brussels, Belgium), A. Michils (Brussels, Belgium)

Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Session: FeNO in airway diseases and asthma-COPD overlap identification
Session type: Thematic Poster
Number: 2617
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Demey (Brussels, Belgium), A. Van Muylem (Brussels, Belgium), S. Perez-Bogerd (Brussels, Belgium), A. Haccuria (Brussels, Belgium), A. Michils (Brussels, Belgium). Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control. 2617

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017

Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral versus central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003

Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009


The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma
Source: Eur Respir J 2005; 25: 289-294
Year: 2005



Different relation between exhaled nitric oxide and lung function with regard to current smoking
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018


Comparison of asthma control test and exhaled nitric oxide to predict asthma control
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010


Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008



The relationship between exhaled breath nitric oxide, induced sputum and airway physiological responses in occupational asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 476s
Year: 2003

Comparison of alveolar nitric oxide concentrations using two different methods for the assessment of small airways inflammation in asthma
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


The effect of lung function tests on exhaled nitric oxide values in infants
Source: Eur Respir J 2005; 26: Suppl. 49, 675s
Year: 2005

Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control
Source: Eur Respir J, 50 (2) 1700392; 10.1183/13993003.00392-2017
Year: 2017



Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence
Source: Eur Respir J 2016; 47: 510-519
Year: 2016



Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model
Source: Eur Respir J 2006; 28: 1236-1244
Year: 2006



Correlation between cold airway hyperresponsiveness and the content of nitric oxide in the exhaled air in patients with bronchial asthma
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014


Increased alveolar and bronchial nitric oxide output in patients with asthmatic symptoms but normal lung function
Source: Eur Respir J 2002; 20: Suppl. 38, 423s
Year: 2002

The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 38s
Year: 2001

Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008